He got the stop-work order. Then the scrambling began. — Harvard Gazette
Wyss Institute’s Don Ingber details rush to hold onto major projects, talented researchers — and system that has driven U.S. innovation .
Wyss Institute’s Don Ingber details rush to hold onto major projects, talented researchers — and system that has driven U.S. innovation .
More efficient and authentic cell creation enables immune studies, drug development
Using this method, scientists discovered key protein and gene activity changes in aging and in a rare disease called progeria.
Gene-editing technologies developed by Harvard’s David Liu demonstrate game-changing potential in two recent cases.
Nicole Maestas on how cuts threaten quality, sustainability of care
Deep-learning algorithm analyzes snapshots for information that could help oncologists tailor treatment intensity.
Julia Merkenschlager explores how secrets of natural immunity can improve vaccines, treatment
Study solves riddle of how mutations in Integrator complex relate to neurodegeneration, cancer
AI model EVE-Vax provides valuable clues about how a virus may evolve
147 students in HMS-based programs receive doctoral degrees amid turbulent times for U.S. research
MD and DMD graduates applaud accomplishments, prepare for challenges